Black Bird Biotech (BBBT) Stock Statistics & Valuation Metrics

Black Bird Biotech has a market cap or net worth of $984.00. The enterprise value is ―.

Black Bird Biotech has 984,047,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Black Bird Biotech’s return on equity (ROE) is 2.55 and return on invested capital (ROIC) is -6571.45%.

The current PE Ratio of Black Bird Biotech is ―. Black Bird Biotech’s PEG ratio is 0.00278.

In the last 12 months, Black Bird Biotech had revenue of 82.56K and earned -1.66M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -233.06K and capital expenditures 0.00, giving a free cash flow of -233.06K billion.

Black Bird Biotech pays an annual dividend of ―, resulting in a dividend yield of ―

Black Bird Biotech upcoming earnings date is ―, ―.

Black Bird Biotech as a current ratio of 0.16, with Debt / Equity ratio of -103.02%

In the past 12 months, Black Bird Biotech has paid 0.00 in taxes.

Black Bird Biotech EV to EBITDA ratio is -0.73, with an EV/FCF ratio of -0.85.

Black Bird Biotech has $5.73K in cash and marketable securities with $748.11K in debt, giving a net cash position of -$742.38K billion.

Gross margin is -67.71%, with operating margin of -1560.42%, and net profit margin of -2009.09%.

The average price target for Black Bird Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―